source
- MassBio CEO warns 2025 may be biotech's toughest year amid China and NIH challengesMassachusetts is widely regarded as the epicenter of biotech because of its world‑class research institutions and vibrant startup ecosystem. MassBio CEO Kendalle Burlin O’Connell said 2025 will pr…
- Haisco licenses inflammatory disease candidate to US startup Sentivera; ViiV's HIV drug cleared for newbornsHaisco Pharmaceutical announced that it has granted a license to US biotech Sentivera for the ex‑China rights to an unnamed inflammatory‑disease candidate. The agreement gives Sentivera the ability…